Cronos Australia
Cronos Australia is an ASX-listed (ASX: CAU) Melbourne-based pharmaceuticals company founded in 2016 with 11-50 employees. No active product portfolio, business model details, or commercial operations are documented in available source material.
- Company typePrivate
- Founded2016
- HeadquartersMelbourne, Australia
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Cronos Australia firmographics
Firmographics- Name
- Cronos Australia
- Website
- https://cronosaustralia.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Cronos Australia is an ASX-listed (ASX: CAU) Melbourne-based pharmaceuticals company founded in 2016 with 11-50 employees. No active product portfolio, business model details, or commercial operations are documented in available source material.
- Ownership category
- akta.pro rank
Cronos Australia industry classification
Industry- Product category
- Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)
Keywords
Where Cronos Australia is headquartered
LocationHeadquarters
- HQ city
- Melbourne
- HQ country
- Australia
- HQ region
- Oceania
Markets served
Cronos Australia business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
Cronos Australia product offering
Product offeringCore offering
Cronos Australia is classified in the source data as a pharmaceuticals company. No specific product lines, therapeutic categories, formulations, or service offerings are described in the available material. The company's web presence is inactive, with cronosaustralia.com currently parked through GoDaddy.
Differentiator
Problem solved
Functional benefit
Cronos Australia technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Cronos Australia competitors and assessment
Company assessmentDirect peers
- Pharmaxis: Pharmaxis is an ASX-listed Australian pharmaceutical company developing therapies for inflammatory and fibrotic diseases. It is a directly comparable small-cap Australian pharmaceutical peer with similar market positioning.
- Mesoblast Limited: Mesoblast is an ASX-listed Australian cell therapy and regenerative medicine company. It is a directly comparable small-cap Australian pharma/biotech peer operating in the same regulatory and capital markets environment.
- Mayne Pharma Group: Mayne Pharma Group is an ASX-listed specialty pharmaceutical company headquartered in Australia, focused on branded and generic pharmaceuticals. It is the most directly comparable peer to Cronos Australia given its Australian domicile, ASX listing, and pharmaceutical product focus.
- Botanix Pharmaceuticals: Botanix Pharmaceuticals is an ASX-listed Australian pharmaceutical company developing cannabinoid-based therapeutics. It is a directly comparable small-cap Australian pharma peer at similar scale and listing tier.
- IDT Australia: IDT Australia is an ASX-listed pharmaceutical manufacturing company also headquartered in Melbourne, providing contract pharmaceutical manufacturing and drug development services. Its Melbourne base and similar headcount make it a particularly close comparable.
- Immutep Limited: Immutep is an ASX-listed Australian biopharmaceutical company developing LAG-3 immunotherapies. It is a directly comparable Australian-listed pharmaceutical company at similar scale and stage.
- Clover Corporation: Clover Corporation is an ASX-listed Australian company developing and commercialising specialty oils and nutrients for pharmaceutical and nutritional applications. It is a directly comparable small-cap Australian health/pharmaceutical peer.
- Starpharma Holdings: Starpharma Holdings is an ASX-listed Australian pharmaceutical company developing dendrimer-based products for pharmaceutical applications. It is a directly comparable small-cap Australian pharmaceutical peer.
- Antisense Therapeutics: Antisense Therapeutics is an ASX-listed Australian biopharmaceutical company focused on antisense oligonucleotide therapeutics. It is a directly comparable small-cap Australian pharmaceutical peer.
Broad incumbents
- CSL Limited: CSL Limited is Australia's largest pharmaceutical and biotechnology company, developing vaccines, plasma products, and therapeutics globally. It is a broad incumbent in the same industry and geography as Cronos Australia, providing a useful benchmark for what an Australian pharma platform can scale into.
Market position
Customer concentration
Cronos Australia social profiles
Digital presenceCronos Australia financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cronos Australia leadership team
Management profileNumber of profiles
Cronos Australia funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cronos Australia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cronos Australia
What does Cronos Australia do?
Cronos Australia is classified in the source data as a pharmaceuticals company. No specific product lines, therapeutic categories, formulations, or service offerings are described in the available material. The company's web presence is inactive, with cronosaustralia.com currently parked through GoDaddy.
When was Cronos Australia founded?
Cronos Australia was founded in 2016. It employs 11 to 50 people.
Where is Cronos Australia based?
Cronos Australia is headquartered in Melbourne, Australia, in the Oceania region.
Who are Cronos Australia's main competitors?
Direct peers on record are Pharmaxis, Mesoblast Limited, Mayne Pharma Group, Botanix Pharmaceuticals, IDT Australia, Immutep Limited, Clover Corporation, Starpharma Holdings and Antisense Therapeutics. CSL Limited is listed as a broad incumbent.
Does Cronos Australia have an API?
No public API is recorded for Cronos Australia.
What industry is Cronos Australia in?
Cronos Australia's product category is Pharmaceuticals. Its primary akta.pro industry code is HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 325412 and its SIC code is 2834.